semaglutide being banned GLP-1 weight-loss drugs are a hot topic when it comes to health. Now, critics are debating whether the medications should be in sports for potentially a performance-enhancing drug The FDA's Decision to Ban

Why Some People Regain Weight After Stopping Weight regain after stopping semaglutide is not a sign of failure

There is no official clinical guidance, published interaction data, or regulatory framework governing the combined use of AOD 9604 and retatrutide

Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinsons disease

This projects secondary analysis of the ISA randomized control trial study will address the following aims: 1) Determine the associations between cultural food security, traditional food intake, cultural connectedness to traditional foods, and a primary outcome: physical activity

Think about where you actually store your medication

Trials of incretin-based therapies routinely monitor gastrointestinal effects nausea, vomiting, diarrhea, constipation, decreased appetite, abdominal discomfort and watch for dehydration, gallbladder problems, pancreatitis, and kidney complications during fluid loss